[1] |
JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling.
Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166.
|
[2] |
WANG Xin, SHI Leilei, ZHANG Yuhan, XIE Yundong, LIU Jiping.
The role of MRPs transporters in drug-induced liver injury
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 229-234.
|
[3] |
LIU Jingjing, DAI Zhong, YANG Jianbo, WANG Ying, XU Beilei, LIU Yue, WANG Qi, MA Shuangcheng.
Spectrum-fect relationship of Ginseng Radix et Rhizoma Rubra and Polygonum Multiflorum Radix Preparata medicinal pair in protection of nerve cells
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 623-628.
|
[4] |
DING Zihe, ZHANG Yanqiong, LIN Na.
Component-effect/toxicity-target correlations of Tripterygium wilfordii in terms of lipid metabolism
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 489-495.
|
[5] |
HUANG Wei, WU Ruiqing, SUN Hua, SHI Jiangong, LIU Qian.
Reversal of multidrug resistance in human oral epithelial cancer cells KBV200 by a natural product
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 403-408.
|
[6] |
DONG Caihong, HU Shaowei, TIAN Guanghuan, KONG Xixian, WU Hongwei, LI Hui.
Comparative study of fresh and dried houttuynia based on the electronic nose and GC-MS technique and correlations between “ fishy odor ” components
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1368-1374.
|
[7] |
LIN Qiqi, LI Xinyang, MENG Fanhao.
Drug resistance mechanism of pemetrexed in non-small cell lung cancer
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1201-1208.
|
[8] |
ZHANG Lei, LI Yuanyuan, XIE Yanming, WANG Lianxin, YANG Xiaochen.
The medication of Breviscapine injection in the treatment of angina pectoris in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 857-861.
|
[9] |
ZHANG Jinlin, LI Yan, CHEN Tao, ZHOU Ying, SONG Yunfeng, JIA Huanhuan, YUAN Yaozuo, CAO Ling, ZHANG Mei, WANG Chen, XU Mingzhe.
Establishment of a bio-relevance dissolution method for lansoprazole enteric capsules
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 702-707.
|
[10] |
ZHU Yulei, LI Xin.
Current Policies and Evaluation of Antimicrobial Management
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(9): 855-859.
|
[11] |
GUI Hong1, MENG Fan-xiang2, HONG Yan-ying1, GAO Xiang1, CUI Xu-ran1, DING Jun-ying1, LIU Qing-quan1, *.
Clinical Distribution, Drug Resistance Characteristics and KPC Gene Expression Analysis of Klebsiella Pneumonia
[J]. Chinese Journal of Pharmacovigilance, 2017, 14(4): 205-208.
|
[12] |
ZHOU Ming-xia, GAO Hui-qin, PENG Xiong-ying, LI Ya-tao, LI Jun-shan, QU Yun-ping, LI Zhen-jiang.
Rapid Identification of Different Processed Products of Rehmannia Glutinosa Formula Granules by FTIR
[J]. Chinese Journal of Pharmacovigilance, 2017, 14(2): 87-89.
|
[13] |
ZHANG Hong-xu, LIU Guang-feng, HAN Feng, HUANG Jin-yue, LING Xin, WANG Yan.
Study on Correlationship between Activity of T Lymphocyte Subsets and NK Cells and Activity of Probiotics in Cancer Patients
[J]. Chinese Journal of Pharmacovigilance, 2016, 13(4): 206-211.
|
[14] |
ZHANG Hong-xu, HAN Feng, HUANG Jin-yue, LING Xin, LIU Guang-feng.
Correlation between Activity of T Lymphocyte Subsets and NK Cells and Antibiotics Use in the Cancer Patients
[J]. Chinese Journal of Pharmacovigilance, 2016, 13(11): 645-650.
|
[15] |
XIA Fang-liang.
Near Infrared Correlation Coefficient Method with Characteristic Spectral Band for Determination of Illegally Added Gliclazide and Hydrochlorothiazide in Capsule Preparations
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(6): 335-337.
|